Abstract
Population: 9 to 15-year old females
Intervention: 9-valent HPV vaccine
Comparison(s): 4-valent or 2-valent HPV vaccines
Outcome: Cases of cervial cancer
- Evidence to recommendation table
- Human papillomavirus (HPV)
Resources
/
SAGE documentation
In 9 to 15-year old females, is 9-valent human papillomavirus vaccine (HPV) vaccine superior to 4-valent or 2-valent HPV vaccines?
Download:
